Compass Therapeutics (CMPX) Other Non-Current Assets (2023 - 2025)
Historic Other Non-Current Assets for Compass Therapeutics (CMPX) over the last 3 years, with Q3 2025 value amounting to $568000.0.
- Compass Therapeutics' Other Non-Current Assets changed 0.0% to $568000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $568000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $568000.0 for FY2024, which is 7750.0% up from last year.
- Per Compass Therapeutics' latest filing, its Other Non-Current Assets stood at $568000.0 for Q3 2025, which was down 0.0% from $568000.0 recorded in Q2 2025.
- In the past 5 years, Compass Therapeutics' Other Non-Current Assets ranged from a high of $568000.0 in Q3 2024 and a low of $320000.0 during Q1 2023
- In the last 3 years, Compass Therapeutics' Other Non-Current Assets had a median value of $320000.0 in 2023 and averaged $432727.3.
- Examining YoY changes over the last 5 years, Compass Therapeutics' Other Non-Current Assets showed a top increase of 7750.0% in 2024 and a maximum decrease of 0.0% in 2024.
- Compass Therapeutics' Other Non-Current Assets (Quarter) stood at $320000.0 in 2023, then soared by 77.5% to $568000.0 in 2024, then changed by 0.0% to $568000.0 in 2025.
- Its last three reported values are $568000.0 in Q3 2025, $568000.0 for Q2 2025, and $568000.0 during Q1 2025.